X
X

Tom O'Brien

CEO

Prior to founding Eclipse in 1993, Tom held several leadership positions throughout his career in the medical device industry. Having mastered both disposable and capital equipment sales for companies like C.R. Bard, Tom’s track record of success quickly established Eclipse as the go-to company to launch new technology in the surgical laser industry.

Over time Tom transitioned Eclipse from a leader in the OR surgical laser market to a key player in the aesthetic laser industry. Starting in 2011 Eclipse began a new mission of increasing adoption of Platelet-rich Plasma on a national level.

His vision and leadership has helped Eclipse become one of the most successful medical device companies in its space. Tom’s new mission is to bring game-changing Eclipse technologies in Platelet-Rich Plasma, Microneedling and Shockwave Therapy to the entire globe.

X


Eclipse PRP®

The Eclipse PRP system utilizes a patented separator gel technology to isolate the platelets while eliminating the undesirable components such as red blood cells and inflammatory white blood cells.

Want to become a provider?

Learn More

Easy Spin 3 Step Process

Step 1: Collect Patients Blood (11ml or 22ml tube) and Centrifuge (10 min.)

Step 2: Extract Platelet Poor Plasma (PPP)

Step 3: Collect Platelet Rich Plasma (PRP) and apply

What is Platelet-Rich Plasma?

Platelet-Rich Plasma (PRP) is an autologous concentrated preparation of platelets and the associated growth factors in a small volume of plasma. Platelets are a natural source of a number of growth factors in their natural and biologically-determined ratios.

What do Platelets do?

Platelets release growth factors which regulate the healing cascade by signaling to surrounding cells to repair damaged tissue and regenerate new tissue. Key growth factors involved in this process include but are not limited to:

  • Platelet-Derived Growth Factor (PDGF)
  • Transforming Growth Factor group (TGF)
  • Epidermal Growth Factor (EGF)
  • Vascular Endothelial Growth Factor (VEGF)
  • Fibroblast Growth Factor (FGF)
  • Keratinocyte Growth Factor (KGF)

Eclipse Difference

Simple: Fewer steps than other PRP (platelet-rich plasma) kits
Excellence: Optimal platelet recovery 87% ± 10%
Fast: Centrifuge with a single spin in a matter of minutes
Patient Friendly: Small volume of blood required
Excellent Value: High volume PRP yield, low cost per mL
~6 mL PRP per 11 mL tube
~12 mL PRP per 22 mL tube
Consistent Platelet Concentration: Allowing for predictable performance

Safety

PRECAUTIONS
1. PRP should be applied to the same patient from whom the blood was drawn.
2. Storage of tubes containing blood at or below 0°C may result in tube breakage.
3. Storage of tubes above 40°C may damage the gel stability.
4. Do not remove conventional rubber stoppers by rolling with a thumb. Remove stoppers with a twist and pull motion.
5. Do not use tubes if foreign matter is present.
6. All liquid preservatives and anticoagulants are clear. Do not use tubes after their expiration date.
7. Do not re-sterilize and do not attempt to clean this product.
8. Do not use products if pouch is damaged.
9. Use prepared platelet concentrate material within 4 hours after drawing blood from patient.

Possible Side Effects
Damage to blood vessels, hematoma, infection and/or irritation.
Temporary or permanent nerve damage that may result in pain or numbness.
As with any injection-based treatment, infection is a slight possibility.

Read More

Regulatory Status

FDA cleared 510(k) Class II medical device. Eclipse PRP is intended for the safe and rapid preparation of autologous platelet-rich plasma (PRP) from a small sample of blood at the patient point of care. The PRP is mixed with autograft or allograft bone prior to application to a bony defect for improving handling characteristics. 510(k) number: BK110035